Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Eurofins Scientific has acquired PerkinElmer, Inc.’s U.S. prenatal screening laboratory services business PerkinElmer Labs/NTD (“NTD”).
read more
Cytovance® Biologics, Inc., a biopharmaceutical contract manufacturing organization specializing in the production of therapeutic proteins and antibodies from mammalian cell culture and microbial fermentation, has announced the addition of Francis (...
read more
Crown Bioscience, a wholly owned subsidiary of Crown Bioscience International and a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research, has announced the launch...
read more
SGS has announced that it is introducing bio-layer interferometry (BLI) for the analysis of molecular interactions in real time, at its laboratory in Mississauga, Canada.
read more
Worldwide Clinical Trials has opened a new, larger depot site in St. Petersburg, Russia. The spacious, new facility – at 1,300 square meters in size – allows for the storage and distribution of a wide range of clinical trial materials with special ...
read more
Axol Bioscience, a biotechnology company specializing in the supply of primary and stem cell-derived human cells for use in disease modelling and drug discovery, announces the launch of its Custom Cell and Tissue Sourcing service.
read more
MilliporeSigma has announced the expansion of its state-of-the-art single use current good manufacturing process (cGMP) facility with the addition of the Mobius® 2000L single-use bioreactor. With the new upstream suite at its Biodevelopment Center in...
read more
Perrigo Company has announced that Mr. Sharon Kochan, Perrigo's Executive Vice President and General Manager, International, will have expanded responsibilities that will now include providing leadership and strategic direction to the Company's ...
read more
Veristat, a full service Clinical Research Organization (CRO), is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology. Spero Oncology is a UK-based CRO specializing in providing clinical ...
read more
Eurofins Scientific has signed an agreement to acquire EAC Corporation Ltd. from Asahi Industries Co., Ltd. in Japan. As part of the acquisition, Asahi and Eurofins will enter into an exclusive supplier contract for a period of 3 years. The ...
read more
CROMSOURCE, an international contract research organization (CRO) providing services to the pharmaceutical, biotechnology, and medical device industries, has announced the appointment of four senior executives to its Management Team.
read more
IMS Health and Quintiles have announced that their respective boards of directors approved a definitive merger agreement, pursuant to which the companies will be combined in an all-stock merger of equals transaction.
read more
Colorcon Inc. has announced its investment in a new film coating manufacturing plant in Indaiatuba – São Paulo State, Brazil, supporting the continued growth of the pharmaceutical industry in South America.
read more
Charles River Laboratories International, Inc. has reported its results for the first quarter of 2016. For the quarter, revenue from continuing operations was $354.9 million, an increase of 10.8% from $320.4 million in the first quarter of 2016.
read more
Marken has expanded their network of qualified third party service providers and customs brokers to reinforce the company's infrastructure and prepare for a significant increase in drug, vaccine, API and ancillary shipment volume.
read more